Pharmaceutical product container
Latest Pfizer Inc. Patents:
- CDCP1 antibodies and antibody drug conjugates
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS
- Dosing Regimen of Avelumab for the Treatment of Cancer
- 3-indol substituted derivatives, pharmaceutical compositions and methods for use
Claims
The ornamental design for a pharmaceutical product container as shown and described.
| 4243144 | January 6, 1981 | Margulies |
| 4736849 | April 12, 1988 | Leonard |
| D444379 | July 3, 2001 | Assargren |
| 6273260 | August 14, 2001 | ColDepietro |
| D455344 | April 9, 2002 | Assargren |
| D455953 | April 23, 2002 | Assargren |
| D655624 | March 13, 2012 | Mehren |
| 20050035023 | February 17, 2005 | Breu |
| 20070246395 | October 25, 2007 | Arnold |
| 20090134051 | May 28, 2009 | Rapp |
| 20160368682 | December 22, 2016 | Mogna |
- Notification of Refusal of Chinese Application No. 202360000637.7 mailed May 24, 2024, 3 pages.
- Office Action from CA Application No. DM/224415 mailed Apr. 29, 2024, 6 pages.
- Examination Subsequent Report for Canadian Patent Application No. 216995, mailed Aug. 1, 2024, 1 page.
- Examination Subsequent Report for Canadian Patent Application No. 216996, mailed Aug. 1, 2024, 1 page.
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Dec 31, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Thomas Huber (Freiburg), Dave Fuhrmeister (Collegeville, PA)
Primary Examiner: Lauren R Calve
Application Number: 29/820,179